Shaoming Li - China Botanic Chairman, CEO and Pres
Chairman
Mr. Shaoming Li is Chairman of the Board, President, Chief Executive Officer of China Botanic Pharmaceutical, Inc. He has served as the Chairman of the board of directors, Chief Executive Officer and President since founding Harbin Renhuang Pharmaceutical Co. Ltd. in 2006. Mr. Li has more than 20 years of experience in the pharmaceutical and finance industry. Mr. Li was the Chairman and Chief Executive Officer of Harbin Renhuang Pharmaceutical Stock Co. Ltd since 1996. From 1984 to 1996, Mr. Li served as Vice Chairman of Shenzhen Health Pharmaceutical Co. Ltd, a company dedicated to drug research, production, and sales. Mr. Li is a professor at Harbin Business University and Northeastern Agriculture University. Mr. Li also served as Vice Chairman of Heilongjiang Provincial Chinese Traditional Medicine Association and Heilongjiang Provincial Medicine Association. Mr. Li graduated from Central University of Finance and Economics in Beijing, China with a degree in finance. since 2006.
| Age | 49 |
| Tenure | 18 years |
| Phone | 917 720 3366 |
| Web | http://www.renhuang.com |
China Botanic Management Efficiency
The company has return on total asset (ROA) of 18.06 % which means that it generated a profit of $18.06 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of (245.75) %, meaning that it created substantial loss on money invested by shareholders. China Botanic's management efficiency ratios could be used to measure how well China Botanic manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 81.6 K in liabilities with Debt to Equity (D/E) ratio of 0.1, which may suggest the company is not taking enough advantage from borrowing. China Botanic Pharma has a current ratio of 10.56, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist China Botanic until it has trouble settling it off, either with new capital or with free cash flow. So, China Botanic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like China Botanic Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for China to invest in growth at high rates of return. When we think about China Botanic's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 8 records | CHAIRMAN Age | ||
| Kornelis Storm | Anheuser Busch Inbev | 73 | |
| Bennett LeBow | Vector Group | 82 | |
| Robert Gamgort | Keurig Dr Pepper | 62 | |
| Louis Camilleri | Philip Morris International | 64 | |
| Martin Barrington | Anheuser Busch Inbev | 68 | |
| Yasutake Tango | Japan Tobacco ADR | 67 | |
| Lucio Noto | Philip Morris International | 81 | |
| Leonard Ainsworth | Ainsworth Game Technology | 93 | |
Management Performance
| Return On Equity | -245.75 | |||
| Return On Asset | 18.06 |
China Botanic Pharma Leadership Team
Elected by the shareholders, the China Botanic's board of directors comprises two types of representatives: China Botanic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Botanic's management team and ensure that shareholders' interests are well served. China Botanic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Botanic's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Weiqiu Dong, CFO and Chief Accounting Officer | ||
| Changxiong Sun, Independent Director, Chairman of Nominations Committee and Member of Audit Committee | ||
| Shaoming Li, Chairman, CEO and Pres | ||
| Bingchun Wu, Independent Director | ||
| Jiang He, Secretary | ||
| Jack Zhao, Independent Director | ||
| Dianjun Pi, Director |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is China Botanic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -245.75 | |||
| Return On Asset | 18.06 | |||
| Current Valuation | 13.64 M | |||
| Shares Outstanding | 37.24 M | |||
| Shares Owned By Insiders | 11.10 % | |||
| Number Of Shares Shorted | 20.46 K | |||
| Price To Earning | 0.09 X | |||
| Price To Book | 0.02 X | |||
| Price To Sales | 0.04 X | |||
| Revenue | 85.08 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards China Botanic in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, China Botanic's short interest history, or implied volatility extrapolated from China Botanic options trading.
Pair Trading with China Botanic
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if China Botanic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Botanic will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Aflac Incorporated could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aflac Incorporated when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aflac Incorporated - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aflac Incorporated to buy it.
The correlation of Aflac Incorporated is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aflac Incorporated moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aflac Incorporated moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aflac Incorporated can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in China Pink Sheet
If you are still planning to invest in China Botanic Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Botanic's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |